The Global Lesinurad Market was valued at USD 42.8 Million in 2024 and is projected to reach USD 58.3 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period (2024–2030). This growth is being driven by increasing prevalence of hyperuricemia, rising demand for urate-lowering therapies, and accelerating research and development activities in gout treatment across pharmaceutical and research sectors globally.

As the pharmaceutical industry transforms toward targeted therapies and precision medicine, the spotlight is on the key manufacturers and research chemical suppliers who are driving innovation, formulation improvements, and therapeutic advancements in gout management. In this blog, we profile the Top 10 Companies in the Lesinurad Industry—a mix of pharmaceutical companies, research chemical suppliers, and API manufacturers shaping the future of hyperuricemia treatment.

---

🔟 1. AbMole BioScience

Headquarters: Houston, Texas, USA
Key Offering: Lesinurad research compounds, analytical standards

AbMole BioScience is a leading supplier of research chemicals and pharmaceutical intermediates, providing high-purity Lesinurad for preclinical and clinical studies. Their portfolio supports drug discovery efforts in metabolic disorders and inflammatory conditions.

Research and Development Focus:

• GMP-grade pharmaceutical intermediates

• Custom synthesis services for research organizations

• Comprehensive analytical characterization support

Download FREE Sample Report: Lesinurad Market – View in Detailed Research Report

---

9️⃣ 2. Ausun Pharmaceutical

Headquarters: Suzhou, China
Key Offering: Lesinurad API, finished dosage forms

Ausun Pharmaceutical specializes in the development and manufacturing of active pharmaceutical ingredients, with strong capabilities in gout therapeutics including Lesinurad production.

Research and Development Focus:

• Large-scale API production capabilities

• Global distribution network for pharmaceutical raw materials

---

8️⃣ 3. Cayman Chemical

Headquarters: Ann Arbor, Michigan, USA
Key Offering: Research-grade Lesinurad, biochemical tools

Cayman Chemical is a prominent manufacturer of biochemical reagents and research compounds, including high-quality Lesinurad for scientific investigation.

Research and Development Focus:

• High-purity reference standards

• GMP facilities for critical pharmaceutical materials

---

7️⃣ 4. MedKoo Biosciences

Headquarters: Morrisville, North Carolina, USA
Key Offering: Lesinurad research chemicals, pharmaceutical intermediates

MedKoo Biosciences focuses on providing novel chemical entities for research, with expertise in gout therapeutic compounds and metabolic disorder treatments.

Research and Development Focus:

• Custom synthesis and scale-up services

• Clinical trial material supply capabilities

Download FREE Sample Report: Lesinurad Market – View in Detailed Research Report

---

6️⃣ 5. Clearsynth

Headquarters: Mumbai, India
Key Offering: Lesinurad standards, metabolite reference materials

Clearsynth specializes in high-purity pharmaceutical reference standards and advanced intermediates for research and development.

Research and Development Focus:

• ISO-certified manufacturing facilities

• Comprehensive quality control and analytical services

---

5️⃣ 6. Target Mol

Headquarters: Boston, Massachusetts, USA
Key Offering: Lesinurad biochemical reagents

Target Mol provides research chemicals and biochemical tools for pharmaceutical development, with consistent quality control across their Lesinurad product line.

Research and Development Focus:

• Broad portfolio of gout therapeutic compounds

• GMP-compliant manufacturing processes

---

4️⃣ 7. UQUIFA

Headquarters: Barcelona, Spain
Key Offering: Lesinurad API, pharmaceutical intermediates

UQUIFA is a global pharmaceutical company with extensive experience in API manufacturing, including urate-lowering agents for global markets.

Research and Development Focus:

• Integrated manufacturing from intermediates to APIs

• Regulatory expertise across major markets

---

3️⃣ 8. MSN Labs

Headquarters: Hyderabad, India
Key Offering: Lesinurad pharmaceutical ingredients

MSN Labs is a research-driven pharmaceutical company with strong capabilities in metabolic disorder treatments and API development.

Research and Development Focus:

• Large-scale API production capabilities

• Comprehensive regulatory support and documentation

---

2️⃣ 9. CHEMO

Headquarters: Milan, Italy
Key Offering: Lesinurad research compounds, custom synthesis

CHEMO focuses on pharmaceutical development and contract manufacturing, with expertise in gout therapeutics and urate-lowering compounds.

Research and Development Focus:

• Specialized manufacturing for rare disease treatments

• Global regulatory compliance expertise

---

1️⃣ 10. Nifty Labs

Headquarters: Ahmedabad, India
Key Offering: Lesinurad custom synthesis, process development

Nifty Labs provides contract research and manufacturing services for pharmaceutical companies, with expertise in metabolic disorder treatments including Lesinurad.

Research and Development Focus:

• Technology transfer and scale-up capabilities

• Quality by design approach to pharmaceutical development

Read Full Report: Lesinurad Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Lesinurad Market and Gout Therapeutics

The Lesinurad market is undergoing significant transformation as research continues to uncover new mechanisms and therapeutic combinations for hyperuricemia management. The industry is investing in novel formulation technologies, combination therapies, and precision medicine approaches to address the growing burden of gout worldwide.

📈 Key Trends Shaping the Gout Therapeutics Market:

• Increasing focus on combination therapies with xanthine oxidase inhibitors

• Advancements in patient stratification and personalized treatment approaches

• Growing research into Lesinurad’s potential applications beyond gout treatment

• Expanding clinical trials investigating Lesinurad in various metabolic disorders

• Regulatory harmonization for urate-lowering therapies across major markets

Read Full Report: Lesinurad Market – View in Detailed Research Report

The companies profiled above are not only supporting research and development in hyperuricemia—they’re pioneering the next generation of targeted gout therapeutics to improve patient outcomes globally.

Download FREE Sample Report: Lesinurad Market – View in Detailed Research Report